JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiersma, D. A.
Right arrow Articles by Roth, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiersma, D. A.
Right arrow Articles by Roth, R. A.

Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung

DA Wiersma and RA Roth

The metabolic clearance of benzo(a)pyrene [B(a)P] was studied in conscious control and 3-methylcholanthrene (3-MC)-pretreated rats. The roles of liver and lung in total body B(a)P clearance were estimated in vivo in 3-MC-treated rats. During a 5-hr period, blood B(a)P concentration decreased rapidly in a biphasic manner. 3-MC pretreatment did not significantly affect the rate constants of B(a)P elimination, but the apparent volume of distribution increased, resulting in an increase in total body B(a)P clearance from 15 +/- 1 to 48 +/- 6 ml/min. Five hours after injection, B(a)P concentrations in most organs were lower in 3-MC-pretreated rats; however, lung B(a)P concentration was greater. In the 3-MC-pretreated rats, first-pass extraction of B(a)P by lung and liver was determined from comparison of areas under arterial blood B(a)P concentration vs. time curves after i.a., i.v. and intrahepatic portal venous administration. Liver had a first-pass extraction of 20% whereas that by lung was 33%. Organ B(a)P concentrations were correlated with the route of B(a)P administration. The results of this study suggest that 1) 3-MC pretreatment increases the apparent volume of B(a)P distribution in vivo, 2) liver and lung of 3-MC-pretreated rats are about equal in their ability to extract circulating B(a)P in vivo and 3) 3-MC pretreatment enhances total body B(a)P clearance by increasing extrahepatic B(a)P elimination.

Volume 226, Issue 3, pp. 661-667, 09/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics.